IE
HUMA icon

Israel Englander’s Humacyte HUMA Stock Holding History

Israel Englander’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Buy
1,909,049
+1,800,895
+1,665% +$1.67M ﹤0.01% 4048
2026
Q1 		$65.6K Sell
108,154
-2,523,836
-96% -$2.62M ﹤0.01% 5404
2025
Q4 		$2.53M Buy
2,631,990
+1,485,152
+129% +$2.1M ﹤0.01% 3734
2025
Q3 		$2M Sell
1,146,838
-1,406,109
-55% -$2.75M ﹤0.01% 4063
2025
Q2 		$5.34M Buy
2,552,947
+1,212,864
+91% +$2.33M ﹤0.01% 2920
2025
Q1 		$2.28M Buy
1,340,083
+421,229
+46% +$1.58M ﹤0.01% 3664
2024
Q4 		$4.64M Sell
918,854
-348,653
-28% -$1.73M ﹤0.01% 2879
2024
Q3 		$6.9M Sell
1,267,507
-331,800
-21% -$2.19M ﹤0.01% 2546
2024
Q2 		$7.68M Buy
1,599,307
+1,334,641
+504% +$6.95M ﹤0.01% 2325
2024
Q1 		$823K Sell
264,666
-1,030,700
-80% -$3.47M ﹤0.01% 4466
2023
Q4 		$3.68M Buy
1,295,366
+68,957
+6% +$177K ﹤0.01% 3056
2023
Q3 		$3.59M Buy
+1,226,409
New +$4.06M ﹤0.01% 3023
2023
Q2 		– Sell
-27,875
Closed -$86K – 6359
2023
Q1 		$86K Buy
+27,875
New +$79.3K ﹤0.01% 5471
2022
Q4 		– Sell
-423,880
Closed -$1.38M – 6756
2022
Q3 		$1.38M Buy
423,880
+25,115
+6% +$96.3K ﹤0.01% 4063
2022
Q2 		$1.28M Buy
398,765
+115,192
+41% +$640K ﹤0.01% 4149
2022
Q1 		$2M Buy
+283,573
New +$1.65M ﹤0.01% 3879
2021
Q3 		– Sell
-54,705
Closed -$557K – 6983
2021
Q2 		$557K Buy
54,705
+8,194
+18% +$84.4K ﹤0.01% 5210
2021
Q1 		$504K Buy
+46,511
New +$508K ﹤0.01% 4822

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Israel Englander's HUMA Position: Q2 2026 in Review

Israel Englander increased its Humacyte (HUMA) stake by 1,665% in Q2 2026, buying an estimated $1.67M and bringing the position to 1,909,049 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

Israel Englander first reported a position in HUMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.68M in Q2 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Israel Englander held 1,909,049 shares of Humacyte worth $1.49M as of Q2 2026.
  • Israel Englander bought 1,800,895 Humacyte shares in Q2 2026, an estimated $1.67M.
  • Humacyte made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4048 holding.
  • Israel Englander first reported a position in Humacyte in Q1 2021 and has held it in 18 quarters since.
  • Israel Englander's Humacyte position peaked at $7.68M in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.